Kagabu, M.; Yoshino, N.; Murakami, K.; Kawamura, H.; Sasaki, Y.; Muraki, Y.; Baba, T.
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. Int. J. Mol. Sci. 2023, 24, 1988.
https://doi.org/10.3390/ijms24031988
AMA Style
Kagabu M, Yoshino N, Murakami K, Kawamura H, Sasaki Y, Muraki Y, Baba T.
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. International Journal of Molecular Sciences. 2023; 24(3):1988.
https://doi.org/10.3390/ijms24031988
Chicago/Turabian Style
Kagabu, Masahiro, Naoto Yoshino, Kazuyuki Murakami, Hideki Kawamura, Yutaka Sasaki, Yasushi Muraki, and Tsukasa Baba.
2023. "Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor" International Journal of Molecular Sciences 24, no. 3: 1988.
https://doi.org/10.3390/ijms24031988
APA Style
Kagabu, M., Yoshino, N., Murakami, K., Kawamura, H., Sasaki, Y., Muraki, Y., & Baba, T.
(2023). Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor. International Journal of Molecular Sciences, 24(3), 1988.
https://doi.org/10.3390/ijms24031988